STRESSEconomicGlobal
Hong Kong needs new funding model to attract global drug makers: AstraZeneca The pharmaceutical giant has conducted more than 60 clinical trials worth US$25.5 million in the city over the last three years.
Published:
News summary
Hong Kong needs new funding model to attract global drug makers: AstraZeneca The pharmaceutical giant has conducted more than 60 clinical trials worth US$25.5 million in the city over the last three years.
- Importance
- Low · 24/100
- Impact direction
- Uncertain